Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01671865 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Jun 2026 → Jun 2028
See other at-risk trials from Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jun 2026 to Jun 2028v13
  2. Primary and study completion dates: Jun 2025 to Jun 2026v12
  3. Primary and study completion dates: Jun 2024 to Jun 2025v11
  4. Primary and study completion dates: Jun 2023 to Jun 2024v10
  5. Primary and study completion dates: Jun 2022 to Jun 2023v9
Show 7 earlier versionsHide 7 earlier versions
  1. Primary and study completion dates: Jun 2021 to Jun 2022v8
  2. Primary and study completion dates: Jun 2020 to Jun 2021v7
  3. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v6
  4. Secondary endpoints: details revised at 3 of 3 entries
    • Publications: 2 to 3
    v5
  5. Primary and study completion dates: Dec 2014 to Jun 2020v4 Show 7 more changesShow less
    • Primary endpoint revised
    • Enrollment target: 60 to 75
    • Eligibility criteria shortened, about 8 words
    • Secondary endpoints expanded, about 10 words
    • Study description shortened, about 29 words
    • Study site revised
    • Collaborators shortened, about 3 words
  6. Primary and study completion dates: Dec 2013 to Dec 2014v3
  7. Study Status, Outcome Measuresv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research study is to identify and study changes in muscle in people with facioscapulohumeral muscular dystrophy using magnetic resonance imaging and spectroscopy.
Trial Details
NCT Number NCT01671865
Lead Sponsor Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Conditions
(from sponsor)		 Facioscapulohumeral Muscular Dystrophy
Related terms Muscular Dystrophy, Facioscapulohumeral
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov